COVID-19 Treatment : Eli Lilly's Bebtelovimab no longer authorized by USFDA Ruchika Sharma1 Dec 2022 3:30 PM ISTEli Lilly and its authorized distributors have paused the commercial distribution of the monoclonal antibody until further notice from the agency.
Setback: Eli Lilly antibody drug fails in a Covid19 study, others go on Ruchika Sharma27 Oct 2020 2:20 PM ISTAnnapolis: US government officials are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalised with Covid-19...
Pharma firms test antibody drugs to treat, prevent Covid-19 Ruchika Sharma15 Aug 2020 9:00 AM ISTNew Delhi: With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies...
Eli Lilly starts phase 3 trial for COVID-19 antibody treatment Ruchika Sharma5 Aug 2020 11:15 AM ISTUS: American pharmaceutical firm Eli Lilly and Company has announced the start of its phase 3 trial to study whether one of its experimental...
FIRST: Eli Lilly begins human trial of potential antibody treatment for COVID-19 Ruchika Sharma4 Jun 2020 9:30 AM ISTThis investigational medicine, referred to as LY-CoV555, is the first to emerge from the collaboration between Eli Lilly and AbCellera to create...
